Transcripts PharmaEssentia Corporation Deutsche Boerse AG

Stocks

Delayed Deutsche Boerse AG 03:34:57 2026-03-09 EDT			5-day change	1st Jan Change
15.50 ^EUR	-.--%		+11.00%	-

08-31	PharmaEssentia Gets US FDA's Approval for Essential Thrombocythemia Treament Drug; Shares Sink 10%	MT
08-28	US FDA approves Takeda, Protagonist's drug for rare blood cancer	RE

No results match your criteria

PharmaEssentia receives China NMPA approval for key Phase III clinical trial

March 27, 2025 at 05:48 am